Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Avelumab AU026497	PD-L1	Monoclonal Antibody	Bavencio®	20 mg/mL	–	2 mg	-80°C	01/2021	125,10 €	view product Max: 10 Min: 3 Step: 1
Bevacizumab B7219H04	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	2 mg	-80°C	06/2018	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab B7223H06	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	2 mg	-80°C	09/2018	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab B7223H17	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	2 mg	-80°C	09/2018	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab B7226H07	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	2 mg	-80°C	12/2018	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab B7230H14	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	2 mg	-80°C	03/2019	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab B7234H02	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	2 mg	-80°C	08/2019	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab B8020H05	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	2 mg	-80°C	10/2019	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab B8800H28	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	yes	2 mg	-80°C	03/2021	185,40 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab H0152B21	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	3 mg	-80°C	09/2017	233,10 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab H0156B21	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	–	3 mg	-80°C	03/2018	233,10 €	view product Max: 10 Min: 2 Step: 1
Bevacizumab H0340H03	VEGF-A	Monoclonal Antibody	Avastin®	25 mg/mL	yes	2 mg	-80°C	07/2024	206,00 €	view product Max: 10 Min: 2 Step: 1
Ipilimumab 8010125	CTLA-4	Monoclonal Antibody	Yervoy®	5 mg/mL	yes	2 mg	-80°C	09/2024	848,00 €	view product Max: 10 Min: 1 Step: 1
Ipilimumab ABE0468	CTLA-4	Monoclonal Antibody	Yervoy®	5 mg/mL	yes	2 mg	-80°C	08/2021	763,20 €	view product Max: 2 Min: 1 Step: 1
Nivolumab 8006657	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2024	307,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab 8039750	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	03/2025	307,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAN6970	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2018	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAP6351	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	10/2018	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAQ3795	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2018	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAU3964	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	05/2019	276,30 €	view product Max: 7 Min: 1 Step: 1
Nivolumab AAW0883	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	01/2019	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAW6409	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	09/2020	276,30 €	view product Max: 7 Min: 1 Step: 1
Nivolumab AAX0742	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	11/2020	276,30 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAY2764	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2021	276,30 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 6302603D04	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2018	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302601E01	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	12/2018	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302607002	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	03/2019	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302613A05	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2019	451,80 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab U001450	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	yes	2 mg	-80°C	04/2022	564,30 €	view product Max: 10 Min: 1 Step: 1

Renal Cell Carcinoma (RCC)

Not looking for Renal Cell Carcinoma (RCC)?

Search our therapeutic molecules product database

© All rights reserved

Evidentic GmbH – Speeding up early drug development